These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20072877)

  • 1. Liposome formulations of hydrophobic drugs.
    Schwendener RA; Schott H
    Methods Mol Biol; 2010; 605():129-38. PubMed ID: 20072877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome Formulations of Hydrophobic Drugs.
    Schwendener RA; Schott H
    Methods Mol Biol; 2017; 1522():73-82. PubMed ID: 27837531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic arabinofuranosyl cytosine derivatives in liposomes.
    Schwendener R; Schott H
    Methods Enzymol; 2005; 391():58-70. PubMed ID: 15721374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
    Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
    Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
    Fahr A; van Hoogevest P; May S; Bergstrand N; S Leigh ML
    Eur J Pharm Sci; 2005 Nov; 26(3-4):251-65. PubMed ID: 16112849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interaction and location in liposomes: correlation with polar surface areas.
    El Maghraby GM; Williams AC; Barry BW
    Int J Pharm; 2005 Mar; 292(1-2):179-85. PubMed ID: 15725564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method.
    Nii T; Ishii F
    Int J Pharm; 2005 Jul; 298(1):198-205. PubMed ID: 15951143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
    Joguparthi V; Anderson BD
    J Pharm Sci; 2008 Jan; 97(1):433-54. PubMed ID: 17918731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of liposomes as injectable-drug delivery systems.
    Ostro MJ; Cullis PR
    Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs.
    Ali MH; Moghaddam B; Kirby DJ; Mohammed AR; Perrie Y
    Int J Pharm; 2013 Aug; 453(1):225-32. PubMed ID: 22766442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB; Betageri GV; Singh M
    J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs.
    Joshi S; Hussain MT; Roces CB; Anderluzzi G; Kastner E; Salmaso S; Kirby DJ; Perrie Y
    Int J Pharm; 2016 Nov; 514(1):160-168. PubMed ID: 27863660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langmuir monolayers of the long-chain alkyl derivatives of a nucleoside analogue and the formation of self-assembled nanoparticles.
    Jin Y; Qiao Y; Li M; Ai P; Hou X
    Colloids Surf B Biointerfaces; 2005 Apr; 42(1):45-51. PubMed ID: 15784325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery.
    McCormack B; Gregoriadis G
    J Drug Target; 1994; 2(5):449-54. PubMed ID: 7704490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and spectroscopic analysis of chromophoric lipids inducing pH-dependent liposome fusion.
    Tomohiro T; Ogawa Y; Okuno H; Kodaka M
    J Am Chem Soc; 2003 Dec; 125(48):14733-40. PubMed ID: 14640648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties.
    Zucker D; Marcus D; Barenholz Y; Goldblum A
    J Control Release; 2009 Oct; 139(1):73-80. PubMed ID: 19508880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of liposomes for studying drug transfer and uptake.
    Fahr A; Liu X
    Methods Mol Biol; 2010; 606():1-10. PubMed ID: 20013385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumour effect of lipophilic derivatives of 5-fluoro-2'-deoxyuridine incorporated into liposomes.
    Supersaxo A; Rubas W; Hartmann HR; Schott H; Hengartner H; Schwendener RA
    J Microencapsul; 1988; 5(1):1-11. PubMed ID: 2974073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes.
    Coimbra M; Isacchi B; van Bloois L; Torano JS; Ket A; Wu X; Broere F; Metselaar JM; Rijcken CJ; Storm G; Bilia R; Schiffelers RM
    Int J Pharm; 2011 Sep; 416(2):433-42. PubMed ID: 21291975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.